BGMD Share Price

Open 0.10 Change Price %
High 0.12 1 Day 0.02 20.00
Low 0.10 1 Week 0.04 50.00
Close 0.12 1 Month 0.05 71.43
Volume 21435 1 Year -0.26 -68.42
52 Week High 0.40
52 Week Low 0.00
BGMD Important Levels
Resistance 2 0.14
Resistance 1 0.13
Pivot 0.11
Support 1 0.11
Support 2 0.10
NASDAQ USA Most Active Stocks
SCHN 26.75 0.38%
SCHN 26.75 0.38%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
DCTH 0.17 6.25%
More..
NASDAQ USA Top Gainers Stocks
LLEN 0.02 100.00%
SPIR 0.02 100.00%
LOCM 0.09 50.00%
GALT 1.94 31.97%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
AEHR 4.99 21.41%
BGMD 0.12 20.00%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
LIWA 0.01 -50.00%
QTWW 0.08 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

BG Medicine, Inc. (NASDAQ: BGMD)

BGMD Technical Analysis 2
As on 21st Feb 2017 BGMD Share Price closed @ 0.12 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.17 & Strong Buy for SHORT-TERM with Stoploss of 0.06 we also expect STOCK to react on Following IMPORTANT LEVELS.
BGMD Target for February
1st Target up-side 0.1
2nd Target up-side 0.12
3rd Target up-side 0.15
1st Target down-side 0.02
2nd Target down-side -0
3rd Target down-side -0.03
BGMD Other Details
Segment EQ
Market Capital 35047004.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.bg-medicine.com
BGMD Address
BGMD
880 Winter Street
Suite 210
Waltham, MA 02451
United States
Phone: 781-890-1199
Fax: 781-895-1119
BGMD Latest News
As BG Medicine, Inc. Trades Do Analysts Recommend You Sell?   The De Soto Edge   - 19th Feb 17
BG Medicine, Inc. (NASDAQ:BGMD) Average Rating At 0   Markets Daily   - 17th Feb 17
Average Rating Of BG Medicine, Inc. (NASDAQ:BGMD) At 0   Markets Daily   - 27th Jan 17
BG Medicine, Inc. (NASDAQ:BGMD) Quarterly Basic Net EPS At 2015-12-31   Equities Focus   - 17th Jun 16
BG Medicine: Nearing The Finish Line   Seeking Alpha   - 03rd Dec 15
BG Medicine (BGMD) Declines On Dilution Fears   CNA Finance (press release)   - 13th Aug 15
First Automated Test for Galectin-3 Now Available in US   GlobeNewswire (press release)   - 06th Jul 15
BG Medicine (NASDAQ: BGMD) Stock Declines | Earnings Report Released   CNA Finance (press release)   - 31st Mar 15
BG Medicine (BGMD) Seeks Additional Indication from FDA for BGM Galectin-3 Test   StreetInsider.com   - 31st Mar 15
BG Medicine (BGMD) Galectin-3 Assigned Payment Code 82777 by CMS   StreetInsider.com (subscription)   - 07th Nov 12
Interactive Technical Analysis Chart BG Medicine, Inc. ( BGMD NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on BG Medicine, Inc.
BGMD Business Profile
BG Medicine, Inc. (BG Medicine) is a life sciences company focused on the discovery, development and commercialization of cardiovascular diagnostics to addresses unmet medical needs. The Company focuses on blood-based tests. Its lead product candidate in development is CardioSCORE, which is a multi-analyte biomarker-based blood test for atherothrombotic cardiovascular disease, commonly known as vulnerable plaque. In March 2011, the Company entered into a supply agreement with Health Diagnostic Laboratory, Inc. (HDL), pursuant to which HDL agreed to purchase manual galectin-3 test kits from the Company and to offer galectin-3 testing services to physicians in the United States. This manual version of Its Galectin-3 test is being marketed in the United States through a number of regional and national laboratory testing facilities. In addition, it has partnered with four diagnostic instrument manufacturers, which are developing automated instrument versions of its galectin-3 test.